Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Eiger Biopharma (EIGR)
Eiger Biopharma (EIGR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 15,091
  • Shares Outstanding, K 44,385
  • Annual Sales, $ 13,480 K
  • Annual Income, $ -96,780 K
  • 60-Month Beta 1.98
  • Price/Sales 1.12
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade EIGR with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.97
  • Most Recent Earnings -0.41 on 11/09/23
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 318.44% ( -558.62%)
  • Historical Volatility 165.88%
  • IV Percentile 58%
  • IV Rank 21.34%
  • IV High 1,310.94% on 11/13/23
  • IV Low 49.26% on 04/18/23
  • Put/Call Vol Ratio 999.99
  • Today's Volume 21
  • Volume Avg (30-Day) 13
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 476
  • Open Int (30-Day) 451

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.57
  • Growth Rate Est. (year over year) +175,363.16%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2700 +20.56%
on 11/10/23
0.4779 -31.89%
on 11/20/23
-0.0655 (-16.75%)
since 11/03/23
3-Month
0.2100 +55.00%
on 10/31/23
0.9399 -65.37%
on 09/05/23
-0.6045 (-65.00%)
since 09/01/23
52-Week
0.2100 +55.00%
on 10/31/23
4.5200 -92.80%
on 12/05/22
-4.2045 (-92.81%)
since 12/02/22

Most Recent Stories

More News
Eiger BioPharma: Q3 Earnings Snapshot

Eiger BioPharma: Q3 Earnings Snapshot

EIGR : 0.3255 (-4.26%)
Stocks Tread Water Before the Open as U.S. Inflation Data Looms

September S&P 500 futures (ESU23) are down -0.02%, and September Nasdaq 100 E-Mini futures (NQU23) are down -0.04% this morning as market participants geared up for a key U.S. consumer inflation report...

ESU23 : 4,491.72s (-0.32%)
NQU23 : 15,435.20s (-0.28%)
ORCL : 115.78 (-1.18%)
AAP : 55.63 (+2.85%)
AAPL : 189.43 (-0.95%)
WRK : 41.55 (-0.43%)
AV-.LN : 421.700 (+0.45%)
WKHS : 0.4100 (+4.67%)
RCKT : 24.75 (+5.68%)
F : 10.70 (+1.13%)
SQSP : 28.51 (-1.25%)
EIGR : 0.3255 (-4.26%)
Eiger to Discontinue Phase 3 LIMT-2 Trial of Peginterferon Lambda in Patients with Chronic Hepatitis Delta

/PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies...

EIGR : 0.3255 (-4.26%)
Eiger BioPharmaceuticals to Present at H.C. Wainwright 25th Annual Global Investment Conference

/PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies...

EIGR : 0.3255 (-4.26%)
Eiger BioPharma: Q2 Earnings Snapshot

Eiger BioPharma: Q2 Earnings Snapshot

EIGR : 0.3255 (-4.26%)
Eiger BioPharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update

/PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies...

EIGR : 0.3255 (-4.26%)
Eiger BioPharmaceuticals to Focus on Metabolic Diseases with Avexitide; David Apelian Takes Helm as CEO

/PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies...

EIGR : 0.3255 (-4.26%)
Eiger BioPharmaceuticals to Host Business Update Call Tomorrow

/PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies...

EIGR : 0.3255 (-4.26%)
Eiger BioPharma: Q1 Earnings Snapshot

Eiger BioPharma: Q1 Earnings Snapshot

EIGR : 0.3255 (-4.26%)
Eiger BioPharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business Update

/PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies...

EIGR : 0.3255 (-4.26%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Eiger BioPharmaceuticals, Inc. is a biopharmaceutical company which develops and manufactures drugs and therapies for the treatment of orphan diseases. Eiger BioPharmaceuticals, Inc., formerly known as Celladon Corporation, is based in Palo Alto, California.

See More

Key Turning Points

3rd Resistance Point 0.3853
2nd Resistance Point 0.3672
1st Resistance Point 0.3463
Last Price 0.3255
1st Support Level 0.3073
2nd Support Level 0.2892
3rd Support Level 0.2683

See More

52-Week High 4.5200
Fibonacci 61.8% 2.8736
Fibonacci 50% 2.3650
Fibonacci 38.2% 1.8564
Last Price 0.3255
52-Week Low 0.2100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar